APPLICATION
NDA018203
TYPE
NDA
ORIGINAL APPROVAL
1979-05-16
LATEST ACTION
1996-04-26
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
LIPOSYN 10%Discontinued
SAFFLOWER OIL 10% (10GM/100ML) · INJECTABLE · INJECTION
Approval history
1996-04-26Labeling · Supplement 27AP
1984-02-24Labeling · Supplement 29AP
1982-06-21Labeling · Supplement 26AP
1982-03-08Labeling · Supplement 24AP
1982-03-01Labeling · Supplement 23AP
1982-02-22Labeling · Supplement 20AP
1982-01-11Labeling · Supplement 18AP
1981-12-17Labeling · Supplement 14AP
1981-08-17Labeling · Supplement 19AP
1981-07-21Labeling · Supplement 16AP
1981-04-14Labeling · Supplement 15AP
1980-05-19Labeling · Supplement 8AP
1980-05-06Labeling · Supplement 9AP
1979-07-03Labeling · Supplement 2AP
1979-07-03Efficacy · Supplement 1AP
1979-05-16Type 1 - New Molecular Entity · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.